{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T10:28:56Z","timestamp":1715250536089},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1987,1,1]],"date-time":"1987-01-01T00:00:00Z","timestamp":536457600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1987]]},"DOI":"10.1007\/bf00542188","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T17:58:49Z","timestamp":1100800729000},"page":"153-158","source":"Crossref","is-referenced-by-count":6,"title":["Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"32","author":[{"given":"F.","family":"Bochner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. G.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Polverino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. M.","family":"Imhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Tregenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"Rolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. G.","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"418","volume":"24","author":"C Bedford","year":"1965","unstructured":"Bedford C, Cummings AJ, Martin BK (1965) A kinetic study of the elimination of salicylate in man. Br J Pharmacol 24: 418?431","journal-title":"Br J Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/clpt.1981.158","volume":"30","author":"F Bochner","year":"1981","unstructured":"Bochner F, Graham GG, Cham BE, Imhoff DM, Haavisto TM (1981) Salicylate metabolite kinetics after several salicylates. Clin Pharmacol Ther 30: 266?275","journal-title":"Clin Pharmacol Ther"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jps.2600580705","volume":"58","author":"G Levy","year":"1969","unstructured":"Levy G, Amsel LP, Elliott HC (1969) Kinetics of salicyluric acid elimination in man. J Pharm Sci 58: 827?829","journal-title":"J Pharm Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/cpt1972132258","volume":"13","author":"G Levy","year":"1972","unstructured":"Levy G, Tsuchiya T, Amsel LP (1972) Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin Pharmacol Ther 13: 258?268","journal-title":"Clin Pharmacol Ther"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1172\/JCI108766","volume":"60","author":"DE Furst","year":"1977","unstructured":"Furst DE, Gupta N, Paulus HE (1977) Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylurate formation. J Clin Invest 60: 32?42","journal-title":"J Clin Invest"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/clpt.1984.81","volume":"35","author":"M G\u00fcnsberg","year":"1984","unstructured":"G\u00fcnsberg M, Bochner F, Graham G, Imhoff D, Parsons G, Cham B (1984) Disposition of and clinical response to salicylates in patients with rheumatoid disease. Clin Pharmacol Ther 35: 585?593","journal-title":"Clin Pharmacol Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/jps.2600610530","volume":"61","author":"T Tsuchiya","year":"1972","unstructured":"Tsuchiya T, Levy G (1972) Biotransformation of salicylic acid to its acyl and phenolic glucuronides in man. J Pharm Sci 61: 800?801","journal-title":"J Pharm Sci"},{"key":"CR8","first-page":"557","volume":"12","author":"RO Day","year":"1982","unstructured":"Day RO, Furst DE, Dromgoole SH, Paulus HE (1982) Decline in steady-state serum salicylic acid concentrations with time in normal volunteers given high dose aspirin. Aust NZ J Med 12: 557?558","journal-title":"Aust NZ J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/cpt1976204464","volume":"20","author":"O Borg\u00e4","year":"1976","unstructured":"Borg\u00e4 O, Odar-Cederl\u00f6f I, Ringberger V-A, Norlin A (1976) Protein binding of salicylate in uremic and normal plasma. Clin Pharmacol Ther 20: 464?475","journal-title":"Clin Pharmacol Ther"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00003088-197904020-00006","volume":"4","author":"R Ekstrand","year":"1979","unstructured":"Ekstrand R, Alvan G, Borg\u00e4 O (1979) Concentration dependent plasma protein binding of salicylate in rheumatoid patients. Clin Pharmacokinet 4: 137?143","journal-title":"Clin Pharmacokinet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt1979263380","volume":"26","author":"DE Furst","year":"1979","unstructured":"Furst DE, Tozer TN, Melmon KL (1979) Salicylate clearance, the resultant of protein binding and metabolism. Clin Pharmacol Ther 26: 380?389","journal-title":"Clin Pharmacol Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00561662","volume":"9","author":"WD Wosilait","year":"1976","unstructured":"Wosilait WD (1976) Theoretical analysis of the binding of salicylate by human serum albumin: The relationship between free and bound drug and therapeutic levels. Eur J Clin Pharmacol 9: 285?290","journal-title":"Eur J Clin Pharmacol"},{"key":"CR13","first-page":"237","volume":"87","author":"PK Smith","year":"1946","unstructured":"Smith PK, Gleason HL, Stoll CG, Ogorzalek S (1946) Studies on the pharmacology of salicylates. J Pharmacol Exp Ther 87: 237?255","journal-title":"J Pharmacol Exp Ther"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00007691-198609000-00014","volume":"8","author":"DM Imhoff","year":"1986","unstructured":"Imhoff DM, Reece PA, Dimitriades E, Ward AD, Bochner F (1986) Direct measurement of salicyl phenolic glucuronide in human urine. Ther Drug Monit 8: 321?325","journal-title":"Ther Drug Monit"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/ard.18.1.49","volume":"18","author":"MW Ropes","year":"1959","unstructured":"Ropes MW, Bennett GA, Lobb S, Jacox R, Jessar RA (1959) Diagnostic criteria for rheumatoid arthritis. Ann Rheum Dis 18: 49?53","journal-title":"Ann Rheum Dis"},{"key":"CR16","first-page":"393","volume":"147","author":"DM Ritchie","year":"1968","unstructured":"Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart J Med 147: 393?406","journal-title":"Quart J Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/clinchem\/25.8.1420","volume":"25","author":"BE Cham","year":"1979","unstructured":"Cham BE, Johns D, Bochner F, Imhoff DM, Rowland M (1979) Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in plasma. Clin Chem 25: 1420?1425","journal-title":"Clin Chem"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","volume":"18","author":"GR Wilkinson","year":"1975","unstructured":"Wilkinson GR, Shand DG (1975) Physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377?390","journal-title":"Clin Pharmacol Ther"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jps.2600570807","volume":"57","author":"M Rowland","year":"1968","unstructured":"Rowland M, Riegelman S (1968) Pharmacokinetics of acetylsalicylic acid and salicylic acid after intravenous administration in man. J Pharm Sci 57: 1313?1319","journal-title":"J Pharm Sci"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJM197208312870903","volume":"287","author":"G Levy","year":"1972","unstructured":"Levy G, Tsuchiya T (1972) Salicylate accumulation kinetics in man. N Engl J Med 287: 430?432","journal-title":"N Engl J Med"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5694\/j.1326-5377.1981.tb132057.x","volume":"2","author":"I Portek","year":"1981","unstructured":"Portek I, Graham GG, Fleming A (1981) Enteric coated pelletized aspirin: gastrointestinal blood loss and bioavailability. Med J Aust 2: 39?40","journal-title":"Med J Aust"},{"key":"CR22","first-page":"409","volume":"17","author":"A Markiewicz","year":"1979","unstructured":"Markiewicz A, Semenowicz K (1979) Time dependent changes in the pharmacokinetics of aspirin. Int J Clin Pharmacol Biopharm 17: 409?411","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2165\/00003088-198005050-00002","volume":"5","author":"M Mandelli","year":"1980","unstructured":"Mandelli M, Tognoni G (1980) Monitoring plasma concentrations of salicylate. Clin Pharmacokinet 5: 424?440","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00542188\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T05:30:18Z","timestamp":1585978218000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00542188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1987]]}},"alternative-id":["BF00542188"],"URL":"https:\/\/doi.org\/10.1007\/bf00542188","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987]]}}}